Pharma supply chains suffer on regulations

Regulatory pressures are at the top of the list of supply chain concerns voiced by pharmaceutical manufacturers in an annual UPS poll. Among respondents with more than $1 billion in sales, an increased regulatory burden was the top concern of 56 percent, while this factor topped the list for a third of smaller drugmakers. Report

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.